InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

8.12
Delayed Data
As of 4:00pm ET
 -0.47 / -5.47%
Today’s Change
7.71
Today|||52-Week Range
103.00
-57.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-18.3M-33.3M-23.4M-26.7M
 
 
 
 
 
Depreciation752.0K689.0K553.0K395.0K
 
 
 
 
 
Total Other Cash Flow3.8M15.7M4.8M6.6M
 
 
 
 
 
Funds From Operations-13.8M-17.0M-18.1M-19.7M
 
 
 
 
 
Funds From/For Other Operating Expenses1.6M-564.0K-1.4M-65.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-15.5M-16.4M-16.7M-19.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-18.9M-8.3M
 
 
 
Decrease In Investments0.000.0012.5M19.8M
 
 
 
Capital Expenditures-47.0K-5.0K-107.0K-65.0K
 
 
 
 
 
Fixed Asset Disposal45.0K0.000.00--
 
 
Net Cash Flow Investing-2.0K-5.0K-6.5M11.5M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings0.000.00------
Long Term Debt Reduction-77.0K-268.0K-395.0K-423.0K
 
 
 
 
 
Net Proceeds Stock Sale14.8M23.3M30.2M80.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-40.0K
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing14.8M23.1M29.8M-383.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-701.0K6.7M6.5M-8.6M